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Detection of Streptococcus pneumoniae 
from culture-negative dried blood spots 
by real-time PCR in Nigerian children with acute 
febrile illness
Pui‑Ying Iroh Tam1,8,9* , Nelmary Hernandez‑Alvarado1, Mark R. Schleiss1, Amy J. Yi1, Fatimah Hassan‑Hanga2, 
Chuma Onuchukwu3, Dominic Umoru4 and Stephen K. Obaro2,5,6,7
Abstract 
Objectives: Acute febrile illness is a common cause of hospital admission, and its associated infectious causes, of 
which a key bacterial causative agent is Streptococcus pneumoniae, contribute to substantial morbidity and mortality. 
We sought to evaluate the utility of real‑time (rt)‑PCR on dried blood spots (DBS) for diagnosis of S. pneumoniae in 
acute febrile illness among children presenting to hospitals in Nigeria. We previously described preliminary results in a 
sample of 537 patients. Here we present data from a larger collection of 1038 patients.
Results: Using rt‑PCR for Streptococcus pneumoniae on 1038 dried blood spots from children prospectively enrolled 
with acute febrile illness, including 79 healthy controls, we detected pneumococcal DNA in nine of 15 blood culture‑
positive specimens, one culture‑negative specimen from a high‑risk group, a culture‑confirmed non‑pneumococcal 
specimen and a healthy control. Six culture‑positive isolates (40%) were negative. Sensitivity was 60%, specificity 
99.7%, positive predictive value 75% and negative predictive value 99.4%. Rt‑PCR of DBS has limited sensitivity in 
blood specimens from acute febrile illness in children.
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Introduction
Acute febrile illness is a common cause of hospital 
admission, and its associated infectious causes contribute 
to substantial morbidity and mortality worldwide. A key 
bacterial causative agent is Streptococcus pneumoniae, 
and in Africa rates of invasive pneumococcal disease 
(IPD) are estimated to be the highest of any continent, 
with recent pooled incidence rates of 62.6 per 100,000 
person-years for children ≤ 5 years of age [1]. The lack of 
robust surveillance systems in low- and middle-income 
countries (LMICs) has made it challenging to diagnose 
the etiology of disease in acute febrile illness. Dried blood 
spots (DBS) hold promise as a method for surveillance 
of pathogens in LMICs, due to the low blood volumes 
involved, low cost, and ability for storage and transport 
at ambient temperature. We have previously conducted 
proof-of-concept studies and demonstrated the high 
detection rate of pneumococcal DNA in spiked samples 
on filter paper by real-time (rt)-PCR, and then evaluated 
clinical specimens with blood culture data. Using rt-PCR 
for pneumococcal DNA on DBS, we documented an 
overall sensitivity of 60% (95% CI 32.3–83.7%) and speci-
ficity of 99.4% (95% CI 98.3–99.9%) [2]. We suspected 
that low rates of pneumococcal detection by culture may 
be due to widespread non-prescription antimicrobial use 
prior to presentation for hospital care. We hypothesized 
that rt-PCR would identify pneumococcal DNA even in 
culture-negative subjects pretreated with antimicrobi-
als. To demonstrate further proof of principle of the util-
ity of real-time (rt)-PCR on dried blood spots (DBS) for 
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diagnosis of S. pneumoniae in acute febrile illness, for 
this study we expanded our evaluation to include a larger 
collection of culture-negative specimens among children 
presenting to hospitals in Nigeria.
Main text
Materials and methods
Between September 2011–June 2015, children ≤ 5 years 
of age who presented to six hospital study sites in Abuja 
and Kano, central and northern Nigeria, respectively, 
with an acute febrile illness (temperature > 38.5 °C) asso-
ciated with difficulty breathing or altered consciousness 
(as subjectively assessed by the clinician of record) were 
prospectively enrolled. Detailed description of these 
clinical sites have been previously described [3]. A vari-
ety of clinical diagnoses were included, and a sample of 
non-matched healthy infant controls was also enrolled. 
After informed consent was obtained, clinical history 
and physical examination findings were collected on a 
detailed questionnaire by the physician. Blood (1–3 mL) 
was obtained and then processed within 4 h for culture 
using the automated BACTEC incubator system (Bec-
ton–Dickinson, Temse, Belgium) and also spotted onto 
Whatman 903 or FTA filter paper (GE Healthcare Bio-
Sciences, Pittsburgh, PA). Healthy controls only had DBS 
obtained. DBS were stored in a − 80  °C freezer before 
transport to the University of Minnesota for processing. 
Using methods described and validated previously [2], 
DBS DNA extractions were used as a template in rt-PCR 
assays targeting lytA gene [4], and RNase P amplification 
was used as a control to confirm recovery of human cel-
lular DNA. Positive results were defined as those with a 
cycle threshold (Ct) < 40. Values ≥ 40 were considered 
equivocal and were repeated using DNA extracted from 
the same DBS specimen. DBS samples were run in dupli-
cate, and were counted as positive when both replicates 
tested positive.
This study was approved by the Ethics Committees of 
the Federal Capital Territory, Federal Medical Center 
Keffi, and Aminu Kano Teaching Hospital, and by the 
University of Nebraska Medical Center and Univer-
sity of Minnesota Institutional Review Boards. Written 
signed informed consent was obtained from the parent 
or guardian.
Results
Microbiological data were available for a total of 1038 
specimens, excluding 79 healthy controls (7.6%). Among 
children with acute febrile illness, 825 (79.4%) blood 
cultures had no growth, 15 (1.4%) grew S. pneumoniae, 
119 (11.5%) were positive for other bacteria, includ-
ing 16 (13.4%) Salmonella Typhi, 6 (5.0%) Salmonella 
Group B, 5 (4.2%) Haemophilus influenzae type b, and 63 
(52.9%) contaminants. Using rt-PCR, S. pneumoniae was 
detected from DBS in 9 culture-positive specimens, in a 
case of culture-confirmed non-pneumococcal bactere-
mia (Haemophilus influenzae) and in one healthy control 
(Fig. 1). Six culture-positive S. pneumoniae isolates (40%) 
were negative for pneumococcal DNA by rt-PCR. Of the 
specimens where there was no growth on blood culture, 
S. pneumoniae was detected from DBS by rt-PCR in one 
culture-negative specimen from a child with a clinical 
diagnosis of sepsis. Using culture as the gold standard, rt-
PCR on DBS for S. pneumoniae has a sensitivity of 60%, 
specificity 99.7%, a positive predictive value of 75% and 
a negative predictive value of 99.4% (Table 1). For evalu-
ation of culture-negative DBS, using PCR as the gold 
standard, culture for S. pneumoniae has a sensitivity of 
75%, specificity 99.4%, positive predictive value of 60%, 
and negative predictive value of 99.7%.
Discussion
There are several notable findings in our study of rt-PCR 
for pneumococcus on DBS of children with acute febrile 
illness, which includes a large collection of culture-neg-
ative specimens, that builds on what has been reported 
previously. Firstly, in a country where pre-vaccination 
studies indicate high rates of pneumococcal nasopharyn-
geal carriage [5], and where pneumococcal conjugate 
vaccine has been introduced but not yet widely distrib-
uted, few children with acute febrile illness are culture-
positive for S. pneumoniae. Secondly, PCR missed over a 
third of S. pneumoniae culture-positive isolates. Thirdly, 
despite evaluating a larger collection of culture-negative 
specimens of children with acute febrile illness, S. pneu-
moniae was detected by rt-PCR in only one culture-nega-
tive DBS in a high-risk patient.
In this study, the culture-negative specimens pos-
sibly correlated with low bacterial density, making 
detection, even by molecular methods, difficult. The 
low sensitivity of molecular detection in DBS com-
pared to blood culture may be due to use of frozen 
versus ambient specimens, low blood sample volume, 
extraction of DNA from the DBS, or the PCR assay 
itself. Earlier studies of PCR on DBS in children with 
a clinical diagnosis of pneumonia demonstrated a sig-
nificant increase in identification of S. pneumoniae by 
PCR compared to blood bacterial culture [6]. However, 
background levels of PCR-positivity in healthy controls 
compared to pneumonia cases were noted in later stud-
ies [4], highlighting the poor specificity of pneumococ-
cal PCR. In the Pneumonia Etiology Research for Child 
Health (PERCH) study, a significant degree of overlap 
existed among S. pneumoniae blood PCR-positive cases 
(5.5–11.5%) and controls (5.3–10.2%) in children from 
African countries [4]. Furthermore, cases confirmed 
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to have non-pneumococcal DNA still had high PCR 
positivity rates for S. pneumoniae (11.2%), and was in 
fact higher than for cases with no confirmed bacterial 
pathogen (6.3%). This contrasted with microbiologi-
cally-confirmed pneumococcal pneumonia, which had 
disappointingly low blood PCR positivity rates (64.3%) 
[4].
Limitations
This study on acute febrile illness included a large pedi-
atric sample size where specimens were collected pro-
spectively from several sites throughout northern and 
central Nigeria. There are some potential limitations. 
Even though filter paper can be stored at ambient tem-
perature, prolonged storage can affect the DNA content 
Eligible Patients (n = 1,041)
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Healthy controls (n = 79)
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No Reference 




Standard (n = 78) 
• Reason: Healthy 
control
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by culture (n = 9) 
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Fig. 1 Standards for reporting of diagnostic accuracy studies (STARD) flowchart for comparative detection of S. pneumoniae DBS by rt‑PCR with 
culture
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[7]. Freeze–thaw cycles can also affect DNA integrity, 
although DNA from archival DBS has been shown to be 
stable after undergoing multiple freeze–thaw cycles [8]. 
The findings are generalizable to other pediatric centers 
in this region, but further studies are required to assess 
if the findings can be applied to other populations and 
settings.
In conclusion, the utility of rt-PCR for the detection 
of Streptococcus pneumoniae on culture-negative DBS 
in children with acute febrile illness is limited. Given the 
observations from this study as well as others such as 
PERCH, new diagnostic approaches beyond pneumococ-
cal PCR protocols may need to be advocated to optimize 
ascertainment of disease burden in LMICs.
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Table 1 Performance of  PCR on  DBS for  Streptococcus 





 Positive 9 3
 Negative 6 1020
